Pall Corporation wins supply contract with Servier
Servier begins construction of Paris-Saclay cluster facility
Servier and Oncodesign join forces to investigate new Parkinson's drug
Bringing preparative chromatography into the spotlight
Servier appoints MaSTherCell to develop its cell therapy manufacturing platform
Sorrento and Servier to develop and commercialise anti-PD-1 antibody
EC warns Novartis and Johnson & Johnson
Hybrigenics and Servier sign three-year research deal
Galapagos receives €4m in milestones from Servier
